$0.01
+0.00 (+27.50%)
Open$0.00
Previous Close$0.00
Day High$0.01
Day Low$0.00
52W High$2.79
52W Low—
Volume—
Avg Volume342.0K
Market Cap223.0K
P/E Ratio—
EPS$-1.34
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 16.46M | 14.50M | 15.97M |
| Net Income | 527.9K | 404.7K | 468.6K |
| Profit Margin | 3.2% | 2.8% | 2.9% |
| EBITDA | 822.7K | 875.9K | 889.3K |
| Free Cash Flow | 305.6K | 207.6K | 283.2K |
| Rev Growth | +9.2% | +19.8% | +5.1% |
| Debt/Equity | 1.41 | 1.41 | 1.44 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |